BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 63.34%
This Quarter Est. Return
1 Year Est. Return
+63.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.4B
AUM Growth
-$782M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
125
New
Increased
Reduced
Closed

Top Buys

1
+$245M
2
+$99.8M
3
+$11.1M
4
AVXS
AveXis, Inc. Common Stock
AVXS
+$10.3M
5
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$5.96M

Top Sells

1
+$69.3M
2
+$14.2M
3
+$12.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$12.8M
5
CERS icon
Cerus
CERS
+$7.06M

Sector Composition

1 Healthcare 92.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$4.3B 37.57%
34,130,161
+20,150
2
$2.37B 20.68%
45,725,556
+10,000
3
$1.04B 9.1%
8,553,864
+2,009,734
4
$720M 6.3%
25,819,768
5
$536M 4.69%
5,905,673
+1,099,190
6
$449M 3.92%
13,779,866
+8,884
7
$197M 1.72%
550,956
8
$165M 1.45%
3,673,175
9
$154M 1.35%
546,708
10
$104M 0.91%
4,804,604
+222,222
11
$91.4M 0.8%
1,133,475
+652
12
$86.7M 0.76%
2,221,706
13
$78.8M 0.69%
1,318,341
14
$69.7M 0.61%
7,288,300
15
$65.1M 0.57%
11,716,784
16
$58.8M 0.51%
503,231
17
$51.4M 0.45%
625,000
+125,000
18
$51.3M 0.45%
2,082,012
-521,557
19
$48.6M 0.43%
1,751,463
+400,000
20
$38.6M 0.34%
2,783,569
21
$36.2M 0.32%
4,113,376
-417,525
22
$31.7M 0.28%
23,271
-3,860
23
$29M 0.25%
276,766
24
$28.4M 0.25%
616,682
-278,740
25
$25.7M 0.22%
10,241,943
-2,811,332
1
2 3 4 5